Speculative Swine Flu Names Seeing Reversal (NVAX, GNBT)
Novavax (NVAX) is down over 10% this morning as investors continue to bail out of their speculative swine flu (or any flu and vaccine) stocks. At $2.12 before the bell, this was as high as $3.88 earlier this week. As of 8:46 we have seen 223,000 shares trade hands.
Generex Biotechnology Corp. (GNBT) is also getting [...]
VS Investor RSS Feed
